Browsing: consensus
Ingevity (NYSE:NGVT) projects net sales of approximately $1.40B for fiscal year 2024, below Wall Street estimates of $1.42B. Adjusted EBITDA…
Delcath Systems (NASDAQ:DCTH) has announced preliminary financial results where, total Q4 and FY revenue are expected to be ~$15.1M vs.…
Ahead of 43rd Annual J.P. Morgan Healthcare Conference, Option Care Health (NASDAQ:OPCH) reported Q4 net revenue of approximately $1.34 billion…
Dzmitry Dzemidovich 10x Genomics (NASDAQ:TXG) expects Q4 revenue of ~$165M, representing 9% growth Q/Q and a 10% decrease Y/Y; the…
Dzmitry Dzemidovich Natera (NASDAQ:NTRA) gave Q4 and FY preliminary results, expects Q4 total revenues of ~$472, up 52% Y/Y, and…
Shutthiphong ChandaengOrchid Island Capital (NYSE:ORC) estimated its Q4 GAAP EPS at $0.07, including an estimated $0.02 per share of net…
Profound Medical (NASDAQ:PROF) reports Q4 preliminary revenue in the approximate range of $4.1 million to $4.2 million, slightly lower than…